NCT05228262Recruiting
Vascular Function, Sarcopenia and Pain in Postmenopausal Osteoporosis
Study on Vascular Function, Sarcopenia and Pain in Treated Postmenopausal Osteoporosis
Source: ClinicalTrials.gov · Last updated 10 Oct 2022 · Not updated for over 12 months - ask the site whether it is still open
Brief summary (registry, in English)
This study aims to follow a cohort of osteoporotic patients treated with anti-osteoporotic drugs and to evaluate the impact of these treatments on the osteoporosis-cardiovascular-sarcopenia triad and on pain.
- Status (registry)
- Recruiting
- Study type
- Interventional
- Enrollment
- 150 (estimated)
- First submitted
- 13 Jan 2022
- Start date
- Feb 2022
- Primary completion date
- Feb 2027
- Lead sponsor
- University Hospital, Clermont-Ferrand
- Diseases
- Osteoporosis
- NCT number
- NCT05228262
What you commit to
- Study type: Interventional
- Planned participants: 150
- From Feb 2022 to the primary completion date, Feb 2027
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Patient with a medical and/or surgical history deemed by the investigator or his/her representative to be incompatible with the trial.
Other illness
- Patient with chronic renal failure, defined as glomerular filtration rate \< 30 mL.min-1 estimated by CKD-EPI.
Other
- Patient under legal protection or deprived of liberty.
- Refusal to participate.
Who the study is looking for
- Women aged 50 years or older with postmenopausal osteoporosis, whether fractured or not, requiring initiation of treatment with antiosteoporotic drugs (bisphosphonates, raloxifene, teriparatide, denosumab and others to come for this indication, including romosozumab), either orally or by injection, as part of their care and management.
- Able to give informed consent to participate in research.
- Affiliation to a Social Security system.
Age in the registry: 50 years to - · Sex: Female · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| CHU de Clermont-Ferrand Coordinator of this site? Confirm its status | Clermont-Ferrand | France | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.